|
Pfizer’s Orphan Leukemia Drug Wins FDA Approval
The FDA has OKed Pfizer’s Bosulif, a once-daily pill to treat chronic myelogenous leukemia (CML), marking the pharma giant’s third new oncology drug approval in a little more than a year.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives